Gilead, Feds Resolve HIV Drug Patent Dispute Amid Appeal

By Hailey Konnath

Gilead Sciences and the federal government have agreed to dismiss all claims and counterclaims in a yearslong intellectual property and contract battle over HIV prevention drugs Truvada and Descovy, according to stipulations of voluntary dismissal filed Wednesday in both the Federal Circuit and Delaware federal court.

 2 documents attached | Read full article » | Save to favorites »